Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Dahm

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 6, 2013
[A. Dahm replies]Anders Dahm
Thrombosis Research|February 17, 2009
Mechanisms of thrombosis related to hormone therapyPer Morten Sandset, Else Høibraaten, Anette Løken Eilertsen, et al.
British Journal of Haematology|January 18, 2006
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal stateAnders Dahm, Frits R Rosendaal, Trine O Andersen, et al.
Blood|February 1, 2003
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisAnders Dahm, Astrid Van Hylckama Vlieg, Bjorn Bendz, et al.
Experimental Hematology & Oncology|March 22, 2018
<i>PAN3</i>-<i>PSMA2</i> fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemiaIoannis Panagopoulos, Ludmila Gorunova, Hege Kilen Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2006
Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?Helene F S Negaard, Anette L Eilertsen, Anders Dahm, et al.
Thrombosis and Haemostasis|July 24, 2015
Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled studyPer Ole Iversen, Anders Dahm, Grethe Skretting, et al.
Spinal Cord|July 10, 2018
Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementationEmil Kostovski, Elena Frigato, Mladen Savikj, et al.
Plos One|May 3, 2017
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trialChristian Prebensen, Marius Trøseid, Thor Ueland, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 6, 2013
[A. Dahm replies]Anders Dahm
Thrombosis Research|February 17, 2009
Mechanisms of thrombosis related to hormone therapyPer Morten Sandset, Else Høibraaten, Anette Løken Eilertsen, et al.
British Journal of Haematology|January 18, 2006
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal stateAnders Dahm, Frits R Rosendaal, Trine O Andersen, et al.
Blood|February 1, 2003
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisAnders Dahm, Astrid Van Hylckama Vlieg, Bjorn Bendz, et al.
Experimental Hematology & Oncology|March 22, 2018
<i>PAN3</i>-<i>PSMA2</i> fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemiaIoannis Panagopoulos, Ludmila Gorunova, Hege Kilen Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2006
Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?Helene F S Negaard, Anette L Eilertsen, Anders Dahm, et al.
Thrombosis and Haemostasis|July 24, 2015
Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled studyPer Ole Iversen, Anders Dahm, Grethe Skretting, et al.
Spinal Cord|July 10, 2018
Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementationEmil Kostovski, Elena Frigato, Mladen Savikj, et al.
Plos One|May 3, 2017
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trialChristian Prebensen, Marius Trøseid, Thor Ueland, et al.
Pageof 1